Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    Septo-Optic Dysplasia
Show Display Options
Rank Status Study
1 Completed Endocrine Dysfunction and Growth Hormone Deficiency in Children With Optic Nerve Hypoplasia
Conditions: Growth Hormone Deficiency;   Septo-Optic Dysplasia;   Hypopituitarism
Intervention: Drug: Nutropin AQ
2 Unknown  Biological Clock Dysfunction in Optic Nerve Hypoplasia
Conditions: Biological Clock Dysfunction;   Optic Nerve Hypoplasia
Interventions: Dietary Supplement: Melatonin;   Dietary Supplement: Placebo Comparator

Indicates status has not been verified in more than two years